Search Results - "LAWTON, Colleen"

RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer by Lawton, Colleen A.F., M.D, Michalski, Jeff, M.D, El-Naqa, Issam, Ph.D, Buyyounouski, Mark K., M.D, Lee, W. Robert, M.D, Menard, Cynthia, M.D, O'Meara, Elizabeth, M.D, Rosenthal, Seth A., M.D, Ritter, Mark, M.D, Seider, Michael, M.D

“…Purpose Radiation therapy to the pelvic lymph nodes in high-risk prostate cancer is required on several Radiation Therapy Oncology Group (RTOG) clinical…”
Get full text

Confirming and Refining Our Existing Postoperative Treatment Strategies Through the Use of Novel Prostate-Specific Positron Emission Tomography (PET) Imaging by Hall, William A., Lawton, Colleen A.F.

Get full text

Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment? by Pathmanathan, Angela U., van As, Nicholas J., Kerkmeijer, Linda G.W., Christodouleas, John, Lawton, Colleen A.F., Vesprini, Danny, van der Heide, Uulke A., Frank, Steven J., Nill, Simeon, Oelfke, Uwe, van Herk, Marcel, Li, X. Allen, Mittauer, Kathryn, Ritter, Mark, Choudhury, Ananya, Tree, Alison C.

“…Radiation therapy to the prostate involves increasingly sophisticated delivery techniques and changing fractionation schedules. With a low estimated α/β ratio,…”
Get full text

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial by Roach, Mack, Moughan, Jennifer, Lawton, Colleen A F, Dicker, Adam P, Zeitzer, Kenneth L, Gore, Elizabeth M, Kwok, Young, Seider, Michael J, Hsu, I-Chow, Hartford, Alan C, Horwitz, Eric M, Yamoah, Kosj, Jones, Christopher U, Michalski, Jeff M, Lee, W Robert, Pisansky, Thomas M, Rabinovitch, Rachel, Rotman, Marvin, Pryzant, Rodger M, Kim, Harold E, Thomas, Charles R, Shipley, William U, Sandler, Howard M

“…The NRG/RTOG 9413 study showed that whole pelvic radiotherapy (WPRT) plus neoadjuvant hormonal therapy (NHT) improved progression-free survival in patients…”
Get full text

Considering benefit and risk before routinely recommending SpaceOAR by Hall, William A, Tree, Alison C, Dearnaley, David, Parker, Christopher C, Prasad, Vinay, Roach, Mack, Lawton, Colleen A F

“…[...]there was an absence of any evaluation as to the reliability of patient masking in the study.6,7 Third, the absence of physician masking is a concern…”
Get full text

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer by Hall, William A., Paulson, Eric, Davis, Brian J., Spratt, Daniel E., Morgan, Todd M., Dearnaley, David, Tree, Alison C., Efstathiou, Jason A., Harisinghani, Mukesh, Jani, Ashesh B., Buyyounouski, Mark K., Pisansky, Thomas M., Tran, Phuoc T., Karnes, R. Jeffrey, Chen, Ronald C., Cury, Fabio L., Michalski, Jeff M., Rosenthal, Seth A., Koontz, Bridget F., Wong, Anthony C., Nguyen, Paul L., Hope, Thomas A., Feng, Felix, Sandler, Howard M., Lawton, Colleen A.F.

“…In 2009, the Radiation Therapy Oncology Group (RTOG) genitourinary members published a consensus atlas for contouring prostate pelvic nodal clinical target…”
Get full text

First, Do No Fistulization by Lawton, Colleen A.F.

Get full text

Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis by Spratt, Daniel E, Malone, Shawn, Roy, Soumyajit, Grimes, Scott, Eapen, Libni, Morgan, Scott C, Malone, Julia, Craig, Julia, Dess, Robert T, Jackson, William C, Hartman, Holly E, Kishan, Amar U, Mehra, Rohit, Kaffenberger, Samuel, Morgan, Todd M, Reichert, Zachery R, Alumkal, Joshi J, Michalski, Jeff, Lee, W Robert, Pisansky, Thomas M, Feng, Felix Y, Shipley, William, Sandler, Howard M, Schipper, Mathew J, Roach, 3rd, Mack, Sun, Yilun, Lawton, Colleen A F

“…There remains a lack of clarity regarding the influence of sequencing of androgen deprivation therapy (ADT) and radiotherapy (RT) on outcomes in prostate…”
Get full text

Prostate Cancer: Improving the Flow of Research by Lawton, Colleen A F

“…Prostate cancer is the most common nonskin cancer diagnosed in U.S. men and kills over 27 000 men annually. Thus, improving the outcomes for patients diagnosed…”
Get full text

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer by Shipley, William U, Seiferheld, Wendy, Lukka, Himanshu R, Major, Pierre P, Heney, Niall M, Grignon, David J, Sartor, Oliver, Patel, Maltibehn P, Bahary, Jean-Paul, Zietman, Anthony L, Pisansky, Thomas M, Zeitzer, Kenneth L, Lawton, Colleen A.F, Feng, Felix Y, Lovett, Richard D, Balogh, Alexander G, Souhami, Luis, Rosenthal, Seth A, Kerlin, Kevin J, Dignam, James J, Pugh, Stephanie L, Sandler, Howard M

“…With a median follow-up of 13 years, a randomized comparison of radiotherapy with or without antiandrogen therapy in patients with a rising PSA level after…”
Get full text

In Reply to Onal et al by Hall, William A, Lawton, Colleen A F

Get full text

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline by Morgan, Scott C, Hoffman, Karen, Loblaw, D Andrew, Buyyounouski, Mark K, Patton, Caroline, Barocas, Daniel, Bentzen, Soren, Chang, Michael, Efstathiou, Jason, Greany, Patrick, Halvorsen, Per, Koontz, Bridget F, Lawton, Colleen, Leyrer, C Marc, Lin, Daniel, Ray, Michael, Sandler, Howard

Get full text

Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer by HORWITZ, Eric M, BAE, Kyounghwa, SHIPLEY, William U, HANKS, Gerald E, PORTER, Arthur, GRIGNON, David J, BRERETON, Harmar D, VENKATESAN, Varagur, LAWTON, Colleen A, ROSENTHAL, Seth A, SANDIER, Howard M

“…To determine whether adding 2 years of androgen-deprivation therapy (ADT) improved outcome for patients electively treated with ADT before and during radiation…”
Get full text

Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer by Lukka, Himanshu R., Deshmukh, Snehal, Bruner, Deborah W., Bahary, Jean-Paul, Lawton, Colleen A.F., Efstathiou, Jason A., Kudchadker, Rajat J., Ponsky, Lee E., Seaward, Samantha A., Dayes, Ian S., Gopaul, Darindra D., Michalski, Jeff M., Delouya, Guila, Kaplan, Irving D., Horwitz, Eric M., Roach, Mack, Feng, Felix Y., Pugh, Stephanie L., Sandler, Howard M., Kachnic, Lisa A.

“…There is considerable interest in very short (ultrahypofractionated) radiation therapy regimens to treat prostate cancer based on potential radiobiological…”
Get full text

Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer by Michalski, Jeff M., M.D, Lawton, Colleen, M.D, El Naqa, Issam, Ph.D, Ritter, Mark, M.D, O'Meara, Elizabeth, C.M.D, Seider, Michael J., M.D, Lee, W. Robert, M.D, Rosenthal, Seth A., M.D, Pisansky, Thomas, M.D, Catton, Charles, M.D, Valicenti, Richard K., M.D, Zietman, Anthony L., M.D, Bosch, Walter R., Ph.D, Sandler, Howard, M.D, Buyyounouski, Mark K., M.D, Ménard, Cynthia, M.D

“…Purpose To define a prostate fossa clinical target volume (PF-CTV) for Radiation Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for…”
Get full text

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202 by Lawton, Colleen A.F., MD, Lin, Xiaolei, MS, Hanks, Gerald E., MD, Lepor, Herbert, MD, Grignon, David J., MD, Brereton, Harmar D., MD, Bedi, Meena, MD, Rosenthal, Seth A., MD, Zeitzer, Kenneth L., MD, Venkatesan, Varagur M., MD, Horwitz, Eric M., MD, Pisansky, Thomas M., MD, Kim, Harold, MD, Parliament, Matthew B., MD, Rabinovitch, Rachel, MD, Roach, Mack, MD, Kwok, Young, MD, Dignam, James J., PhD, Sandler, Howard M., MD

“…Abstract Purpose Trial*** was a phase III randomized trial designed to determine the optimal duration of androgen deprivation therapy (ADT) when combined with…”
Get full text

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate by Roy, Soumyajit, Romero, Tahmineh, Michalski, Jeff M., Feng, Felix Y., Efstathiou, Jason A., Lawton, Colleen A.F., Bolla, Michel, Maingon, Philippe, de Reijke, Theo, Joseph, David, Ong, Wee Loon, Sydes, Matthew R., Dearnaley, David P., Tree, Alison C., Carrier, Nathalie, Nabid, Abdenour, Souhami, Luis, Incrocci, Luca, Heemsbergen, Wilma D., Pos, Floris J., Zapatero, Almudena, Guerrero, Araceli, Alvarez, Ana, San-Segundo, Carmen Gonzalez, Maldonado, Xavier, Reiter, Robert E., Rettig, Matthew B., Nickols, Nicholas G., Steinberg, Michael L., Valle, Luca F., Ma, T. Martin, Farrell, Matthew J., Neilsen, Beth K., Juarez, Jesus E., Deng, Jie, Vangala, Sitaram, Avril, Norbert, Jia, Angela Y., Zaorsky, Nicholas G., Sun, Yilun, Spratt, Daniel, Kishan, Amar U.

“…PURPOSEThe surrogacy of biochemical recurrence (BCR) for overall survival (OS) in localized prostate cancer remains controversial. Herein, we evaluate the…”
Get full text

An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions by Lawton, Colleen A., M.D, DeSilvio, Michelle, Ph.D, Roach, Mack, M.D, Uhl, Valery, M.D, Kirsch, Robert, M.D, Seider, Michael, M.D, Rotman, Marvin, M.D, Jones, Christopher, M.D, Asbell, Sucha, M.D, Valicenti, Richard, M.D, Hahn, Stephen, M.D, Thomas, Charles R., M.D

“…Purpose This trial was designed to test the hypothesis that total androgen suppression and whole pelvic radiotherapy (WPRT) followed by a prostate boost…”
Get full text

To Radiate or Not to Radiate—The Challenges of Pelvic Reirradiation by Kamran, Sophia C., Zelefsky, Michael, Nguyen, Paul L., Lawton, Colleen A.F.

“…Patients who receive pelvic radiation are at risk for both local recurrences of their primary malignancy or for the development of a new malignancy in the…”
Get full text

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610 by ROACH, Mack, BAE, Kyounghwa, SPEIGHT, Joycelyn, WOLKOV, Harvey B, RUBIN, Phillip, LEE, R. Jeffrey, LAWTON, Colleen, VALICENTI, Richard, GRIGNON, David, PILEPICH, Miljenko V

“…Radiation Therapy Oncology Group (RTOG) 8610 was the first phase III randomized trial to evaluate neoadjuvant androgen deprivation therapy (ADT) in combination…”
Get full text